Table 4 One-year clinical outcomes

From: Mechanisms underlying superior outcomes of transcatheter aortic valve implantation with the latest balloon expandable valve

 

Overall

Small (20 mm or 23 mm)

Large (26 mm or 29 mm)

Matched cohort

S3UR

S3

HR

95% CI

p

S3UR

S3

HR

95% CI

p

S3UR

S3

HR

95% CI

p

All-cause mortality

77 (10.3)

100 (13.4)

0.79

0.602–1.036

0.089

44 (9.7)

68 (14.7)

0.686

0.483–0.975

0.036

33 (9.8)

32 (11.2)

0.984

0.638–1.516

0.94

Stroke

7 (0.9)

25 (3.4)

0.385

0.186–0.798

0.01

4 (0.9)

19 (4.2)

0.359

0.152–0.851

0.02

3 (1.0)

6 (2.3)

0.473

0.119–1.872

0.286

Heart failure rehospitalization

10 (1.4)

19 (2.7)

0.466

0.228–0.952

0.036

6 (1.4)

13 (3.0)

0.366

0.144–0.932

0.035

4 (1.4)

6 (2.2)

0.686

0.221–2.128

0.514

  1. Cumulative even rate (%).
  2. S3UR SAPIEN 3 Ultra RESILIA, S3 SAPIEN 3, HR Hazard ratio, CI Confidence interval.
  3. P-values, HR, and 95% CI from the COX proportional hazard model.
Back to article page